Literature DB >> 30543833

Factors associated with suspected nonmelanoma skin cancers, dysplastic nevus, and cutaneous melanoma among first-time SPOTme screening program participants (2009-2010).

Derek Beaulieu1, Hensin Tsao2, Dominique S Michaud3, Jean-Phillip Okhovat4, Allan C Halpern5, Alan C Geller6.   

Abstract

BACKGROUND: There have been no studies of the American Academy of Dermatology's SPOTme skin cancer screening program that have collectively analyzed the factors associated with suspected diagnoses of basal cell carcinoma (BCC), squamous cell carcinoma (SCC), dysplastic nevus (DN), and cutaneous melanoma (CM).
OBJECTIVE: Describe the demographics, risk factors, and access to care profile associated with suspected diagnoses of BCC, SCC, DN, and CM among first-time SPOTme screenees from 2009 to 2010.
METHODS: We conducted a cross-sectional analysis of data from SPOTme skin cancer screenings conducted in 2009 and 2010. We performed multivariable logistic regression analysis for each diagnosis, incorporating traditional demographic, access to care, and risk factor variables in the models.
RESULTS: Men, those without a regular dermatologist, persons reporting recently changing moles, and those with a personal history of melanoma were at increased risk for each of the suspected diagnoses analyzed. The uninsured were at increased risk for the suspected malignancies (BCC, SCC, and CM). LIMITATIONS: Lack of histological confirmation for diagnoses; cross-sectional design.
CONCLUSION: Among first-time SPOTme participants, suspected diagnoses of BCC, SCC, DN, and CM shared several associated factors which may be considered when planning outreach and screening for populations at risk for skin cancer.
Copyright © 2018. Published by Elsevier Inc.

Entities:  

Year:  2018        PMID: 30543833     DOI: 10.1016/j.jaad.2018.12.010

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  1 in total

1.  A geographically based cross-sectional analysis of SPOT me skin cancer screening data.

Authors:  Derek Beaulieu; Hensin Tsao; Dominique S Michaud; Jean-Phillip Okhovat; Allan C Halpern; Missy Lundberg; Alan C Geller
Journal:  J Am Acad Dermatol       Date:  2020-06-10       Impact factor: 15.487

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.